First Time Loading...

Gilead Sciences Inc
NASDAQ:GILD

Watchlist Manager
Gilead Sciences Inc Logo
Gilead Sciences Inc
NASDAQ:GILD
Watchlist
Price: 67.86 USD 1.27% Market Closed
Updated: May 16, 2024

Gilead Sciences Inc
Total Other Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Gilead Sciences Inc
Total Other Income Peer Comparison

Comparables:
ABBV
AMGN
MRNA
VRTX
REGN

Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors

Company Total Other Income CAGR 3Y CAGR 5Y CAGR 10Y
Gilead Sciences Inc
NASDAQ:GILD
Total Other Income
$252m
CAGR 3-Years
22%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Total Other Income
-$4.7B
CAGR 3-Years
6%
CAGR 5-Years
-204%
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Total Other Income
$151m
CAGR 3-Years
126%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Moderna Inc
NASDAQ:MRNA
Total Other Income
-$8m
CAGR 3-Years
-19%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Other Income
-$15.3m
CAGR 3-Years
N/A
CAGR 5-Years
-61%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Other Income
-$31.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Gilead Sciences Inc's Total Other Income?
Total Other Income
252m USD

Based on the financial report for Mar 31, 2024, Gilead Sciences Inc's Total Other Income amounts to 252m USD.

What is Gilead Sciences Inc's Total Other Income growth rate?
Total Other Income CAGR 5Y
-16%

Over the last year, the Total Other Income growth was 47%. The average annual Total Other Income growth rates for Gilead Sciences Inc have been 22% over the past three years , -16% over the past five years .